Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia

• Status: Unknown status
• Trial end date: 2017-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Neonatal Jaundice occurs in 60% of term infants and 80% of premature infants. Although it is transient, it is associated with high rate of readmission of patients in the first week of infancy. Neonatal jaundice can cause neurological complications and kernicterus. Considering the fact that there have been a lot of studies on probiotic role in management of necrotizing enterocolitis (NEC) and few studies on their role in neonatal jaundice, we carried out this study to determine the efficacy and safety of probiotics in neonatal hyperbilirubinemia in infants hospitalized in children hospital in Bandar Abbas.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hormozgan University of Medical Sciences

Criteria

Inclusion Criteria:

• Between 2 and 28 days old

• Having jaundice

• Gestational age between 35-42 weeks

Exclusion Criteria:

• Less than 2 days or more than 28 days old

• Gestational age out of the range of 35-42 weeks

• Infants whose parents refused to cooperate

• Patients with sepsis and other comorbid conditions